Literature DB >> 23945322

[Local recurrence of pheochromocytoma associated with von Hippel-Lindau disease 26 years after bilateral adrenalectomy : a case report].

Naoki Fujita1, Jotaro Mikami, Hiromi Murasawa, Akiko Okamoto, Atsushi Imai, Shingo Hatakeyama, Hirofumi Ishimura, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Chikara Ohyama, Satoko Morohashi, Hiroshi Kijima.   

Abstract

A 60-year-old man who had undergone left adrenalectomy and right partial adrenalectomy for bilateral pheochromocytoma 26 years ago was found to have an elevated serum noradrenaline (NA) and dopamine (DA) during a long-term follow-up. At the time of right partial adrenalectomy, the normal part of the right adrenal gland was preserved. His cousin and second cousin had pheochromocytoma associated with von Hippel-Lindau (VHL) disease. His eldest daughter had cerebellar hemangioblastoma. Computed tomography and magnetic resonance imaging revealed a tumor which was 17 mm in diameter with contrast enhancement in the vicinity of the S6 region in the liver. 123 I-metaiodobenzylguanidine (MIBG) scintigraphy showed an abnormal accumulation in the same area. The tumor was surgically removed under the diagnosis of recurrence of pheochromocytoma. Histopathological examination revealed findings consistent with recurrent pheochromocytoma. After operation, serum NA and DA returned to normal range and the abnormal up-take on 123I-MIBG scintigraphy disappeared. Genetic testing revealed that the patient and his daughter had VHL disease. An extensive genetic examination and long-term follow-up should be considered for the present family.

Entities:  

Mesh:

Year:  2013        PMID: 23945322

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  1 in total

1.  A Family with Von Hippel-Lindau Syndrome: The Findings of Indium-111 Somatostatin Receptor Scintigraphy, Iodine-123 Metaiodobenzylguanidine Scintigraphy and Single Photon Emission Computerized Tomography.

Authors:  Pelin Arıcan; Berna Okudan Tekin; Seniha Naldöken; Rıza Şefizade; Dilek Berker
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.